International Biotechnology (LON:IBT – Get Free Report) insider Alexa Henderson acquired 6,996 shares of the firm’s stock in a transaction on Wednesday, February 19th. The shares were bought at an average price of GBX 711 ($8.95) per share, for a total transaction of £49,741.56 ($62,591.62).
International Biotechnology Stock Performance
LON IBT opened at GBX 712.07 ($8.96) on Thursday. The business’s 50 day moving average price is GBX 701.96 and its 200-day moving average price is GBX 691.28. International Biotechnology has a fifty-two week low of GBX 596 ($7.50) and a fifty-two week high of GBX 736 ($9.26). The company has a market cap of £255.78 million, a P/E ratio of 6.79 and a beta of 0.21.
International Biotechnology Increases Dividend
The company also recently announced a dividend, which was paid on Friday, January 24th. Stockholders of record on Thursday, December 19th were paid a GBX 15.56 ($0.20) dividend. The ex-dividend date of this dividend was Thursday, December 19th. This represents a dividend yield of 2.21%. This is an increase from International Biotechnology’s previous dividend of $14.50. International Biotechnology’s dividend payout ratio is currently 27.67%.
International Biotechnology Company Profile
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Read More
- Five stocks we like better than International Biotechnology
- What is the Hang Seng index?
- Fastenal : Growth Trends, Challenges & Key Investment Insights
- EV Stocks and How to Profit from Them
- 2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Biogen Stock Is Mutating Into a Value Play
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.